Blasi, Maria Antonietta
 Distribuzione geografica
Continente #
NA - Nord America 3.116
AS - Asia 2.213
EU - Europa 2.182
SA - Sud America 441
AF - Africa 67
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 8.027
Nazione #
US - Stati Uniti d'America 3.030
SG - Singapore 1.004
DE - Germania 576
CN - Cina 458
BR - Brasile 378
IT - Italia 370
SE - Svezia 340
VN - Vietnam 255
FR - Francia 198
IN - India 126
GB - Regno Unito 125
UA - Ucraina 114
IE - Irlanda 103
FI - Finlandia 99
PL - Polonia 74
ID - Indonesia 63
RU - Federazione Russa 60
HK - Hong Kong 55
JP - Giappone 53
CA - Canada 37
BD - Bangladesh 35
TR - Turchia 31
MX - Messico 25
AR - Argentina 20
NL - Olanda 20
BE - Belgio 19
IQ - Iraq 19
IR - Iran 19
ZA - Sudafrica 18
ES - Italia 17
AT - Austria 14
CI - Costa d'Avorio 14
SA - Arabia Saudita 13
EC - Ecuador 12
KR - Corea 11
PH - Filippine 9
CH - Svizzera 8
UZ - Uzbekistan 8
CO - Colombia 7
JM - Giamaica 7
MA - Marocco 7
PK - Pakistan 7
VE - Venezuela 7
AZ - Azerbaigian 6
CL - Cile 6
CZ - Repubblica Ceca 6
LT - Lituania 6
TN - Tunisia 6
AL - Albania 5
JO - Giordania 5
KZ - Kazakistan 5
NO - Norvegia 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
DZ - Algeria 4
EG - Egitto 4
LK - Sri Lanka 4
PY - Paraguay 4
RS - Serbia 4
TW - Taiwan 4
UY - Uruguay 4
BG - Bulgaria 3
BZ - Belize 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GR - Grecia 3
HR - Croazia 3
PT - Portogallo 3
RO - Romania 3
SN - Senegal 3
UG - Uganda 3
AM - Armenia 2
BH - Bahrain 2
BO - Bolivia 2
CR - Costa Rica 2
KE - Kenya 2
KG - Kirghizistan 2
LB - Libano 2
MY - Malesia 2
NI - Nicaragua 2
NP - Nepal 2
PA - Panama 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
AI - Anguilla 1
AW - Aruba 1
BN - Brunei Darussalam 1
DK - Danimarca 1
DM - Dominica 1
GE - Georgia 1
GT - Guatemala 1
IL - Israele 1
IS - Islanda 1
LU - Lussemburgo 1
LV - Lettonia 1
ML - Mali 1
MM - Myanmar 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
Totale 8.022
Città #
Singapore 576
Chandler 417
Ashburn 310
San Jose 293
Beijing 113
New York 110
Dublin 102
Los Angeles 97
Ho Chi Minh City 82
San Mateo 78
Ann Arbor 77
Hanoi 74
Jacksonville 70
Warsaw 65
Rome 64
Helsinki 62
Jakarta 59
Lauterbourg 59
Wilmington 59
Fairfield 57
Munich 53
Nanjing 51
Hong Kong 50
Tokyo 48
Boston 46
São Paulo 42
Hefei 40
Marseille 40
Woodbridge 39
Frankfurt am Main 38
Seattle 38
Dallas 36
Milan 35
Nürnberg 35
Cattolica 32
North Bergen 32
Dearborn 30
Princeton 30
Moscow 29
The Dalles 29
Chicago 28
Council Bluffs 27
Bremen 26
Houston 26
Hyderabad 23
Orem 23
Lancaster 22
Santa Clara 22
Brussels 19
Cambridge 19
Lawrence 19
London 19
St Louis 19
Nanchang 18
Buffalo 17
Paris 16
Redwood City 16
Abidjan 14
Brooklyn 14
Denver 13
Izmir 13
Kent 13
Mountain View 13
Da Nang 12
Amsterdam 11
Guangzhou 11
Johannesburg 11
Seoul 11
Stockholm 11
Toronto 11
Augusta 10
Belo Horizonte 10
Haiphong 10
Kish 10
Lappeenranta 10
Mexico City 10
Nuremberg 10
Atlanta 9
Baghdad 9
Chennai 9
Montreal 9
Redmond 9
Shenyang 9
Trabia 9
Washington 9
Düsseldorf 8
Hebei 8
Kocaeli 8
Melegnano 8
Rio de Janeiro 8
Salt Lake City 8
San Francisco 8
Tianjin 8
City of London 7
Falkenstein 7
Falls Church 7
Hangzhou 7
Jiaxing 7
Kingston 7
Mumbai 7
Totale 4.369
Nome #
Pembrolizumab as first-line treatment for metastatic uveal melanoma 342
Intravitreal dexamethasone implant for acute exudative polymorphous vitelliform maculopathy 228
Uveal melanoma: evaluation of extrascleral extension using thin-section MR of the eye with surface coils 225
A prospective analysis of ¹⁸F-FDG PET/CT in patients with uveal melanoma: comparison between metabolic rate of glucose (MRglu) and standardized uptake value (SUV) and correlations with histopathological features. 209
Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: safety and efficacy evaluation 201
Evaluation of intraorbital injection of rituximab for treatment of primary ocular adnexal lymphoma. A pilot study. 194
ARCUATE NERVE FIBER LAYER CHANGES AFTER INTERNAL LIMITING MEMBRANE PEELING IN IDIOPATHIC EPIRETINAL MEMBRANE 182
Immunotherapy and radiotherapy in melanoma: a multidisciplinary comprehensive review 177
Orbital and eyelid b-cell lymphoma: A multicenter retrospective study 175
Unique genomic profile associated with pediatric uveal melanoma 167
Multidisciplinary ocular and periocular cancers meetings: implementation in a tertiary referral center and analysis over a 12-months period 164
Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: Safety and efficacy evaluation. 160
Oncologia Oculare 159
Nomogram for predicting radiation maculopathy in patients treated with Ruthenium-106 plaque brachytherapy for uveal melanoma 152
Hepatic Radiotherapy in Addition to Anti-PD-1 for the Treatment of Metastatic Uveal Melanoma Patients 150
Ruthenium brachytherapy for uveal melanomas: Factors affecting the development of radiation complications 149
BRACHYTHERAPY ALONE or with NEOADJUVANT PHOTODYNAMIC THERAPY for AMELANOTIC CHOROIDAL MELANOMA: Functional Outcomes and Local Tumor Control 147
Lymphoepithelioma-like carcinoma involving the lacrimal gland and infiltrating the eyelids. 146
INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures 143
The pediatric choroidal and ciliary body melanoma study: A survey by the European Ophthalmic Oncology Group 142
Evaluation of intraorbital injection of rituximab for treatment of primary ocular adnexal lymphoma: a pilot study 141
Photodynamic therapy with verteporfin for symptomatic circumscribed choroidal hemangioma: five-year outcomes 140
Photodynamic Therapy in Ocular Oncology 139
Metabolic Rate of glucose (MRglu) but not standardized uptake value (SUV) can distinguish high risk from low risk uveal melanoma: experience in 20 patients 135
INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures 135
Intralesional interferon-α for conjunctival mucosa-associated lymphoid tissue lymphoma: long-term results 134
Eye Pathology 134
Cisplatin, dacarbazine and vinblastine as first line chemotherapy for liver metastatic uveal melanoma in the era of immunotherapy: A single institution phase II study 131
Personalized re-treatment strategy for uveal melanoma local recurrences after interventional radiotherapy (brachytherapy): Single institution experience and systematic literature review 129
Conjunctival melanoma: Genetic and epigenetic insights of a distinct type of melanoma 128
Avatar: Analysis for visual acuity prediction after eye interventional radiotherapy 128
Advanced ocular surface squamous cell carcinoma (OSSC): long-term follow-up 128
Pigmented Lesions of Ocular Fundus: Clinical Aspects 124
Immunological backbone of uveal melanoma: Is there a rationale for immunotherapy? 124
Long-term outcomes of primary ocular adnexal lymphoma treatment with intraorbital rituximab injections. 123
Morpho-functional evaluation of torpedo maculopathy with optical coherence tomography angiography and microperimetry 123
Avatar: Analysis for visual acuity prediction after eye interventional radiotherapy 119
Exclusive Ru-106 brachytherapy for the management of a recurrent corneo: Conjunctival squamous cell carcinoma 118
Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma 117
Flogosi tumorali, traumatiche ed orbitarie 116
High-Dose-Rate Interstitial Brachytherapy (Interventional Radiotherapy) for Conjunctival Melanoma with Orbital Extension 113
Multimodal imaging evaluation of combined hamartoma of the retina and retinal pigment epithelium 111
The Role of Radiotherapy in Orbital Pseudotumor: A Systematic Review of Literature 111
ORIFICE (Interventional Radiotherapy for Face Aesthetic Preservation) Study: Results of Interdisciplinary Assessment of Interstitial Interventional Radiotherapy (Brachytherapy) for Periorificial Face Cancer 110
Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory study 104
Efficacy of immune checkpoint inhibitors in different types of melanoma 103
Tectonic Keratoplasty to Restore the Bulbar Wall after Block Excision of Benign and Malignant Intraocular Tumors 101
Supportive treatment to chemotherapy with MMC, in patients with ocular surface squamous neoplasia or conjunctival melanocytic tumor 97
Photodynamic therapy for vasoproliferative retinal tumors 97
Artificial intelligence with ChatGPT 4: a large language model in support of ocular oncology cases 95
The Role of Multidisciplinary Ocular and Periocular Cancers Meetings in Uveal Melanoma Management: A 2-Year Analysis 94
Line-Field Confocal Optical Coherence Tomography Evaluation of Eyelid Skin Lesions 92
Post-operative interventional radiotherapy (brachytherapy) in advanced ocular surface and eyelid tumors as an alternative to surgical retreatment 88
Orbital cellulitis and massive chemosis as first sign of a cilio-choroidal malignant melanoma without extraocular extension: A case report 88
Long-term outcomes of primary ocular adnexal lymphoma treatment with intraorbital rituximab injections 87
Mitomycin C or interferon as adjuvant therapy to surgery for ocular surface squamous neoplasia: comparative study 83
25-Gauge Pars Plana Vitrectomy for Retained Lens Fragments in Complicated Cataract Surgery 75
BIGH3 mutation spectrum in corneal dystrophies 73
Nomogram for predicting radiation maculopathy in patients treated with Ruthenium-106 plaque brachytherapy for uveal melanoma 63
Incidental Finding of Suprachoroidal Space’s Silicone Oil Migration: A Tumor-Mimicking Lesion and Its Clinical Management 61
Necrotic uveal melanoma with orbital inflammation 59
Escherichia coli endophthalmitis after trans-scleral resection of uveal melanoma 57
Totale 8.140
Categoria #
all - tutte 31.778
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.778


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202165 0 0 0 0 0 0 0 0 0 0 60 5
2021/2022545 65 26 27 40 19 14 12 87 22 35 77 121
2022/20231.219 157 155 88 198 61 145 78 88 137 34 57 21
2023/2024535 17 146 32 24 27 93 26 30 8 14 64 54
2024/20251.153 30 32 77 34 119 51 17 44 185 109 236 219
2025/20263.120 437 78 179 467 531 154 641 191 211 217 14 0
Totale 8.140